Pharma’s Space Trails Entering Transformative Era - Keytruda’s Been There

Merck and Lilly are among the leading pharma players using space-based research to power drug development. From reusable satellites to process drugs in low earth orbit to biomanufacturing labs experts discuss R&D opportunities in the starry canvas above.

Space holds huge potential for pharma R&D
(Shutterstock/AI-generated)

Pharma appears to be at the dawn of a transformative era in space-based research. From leveraging microgravity effects to biomanufacturing in orbit for ultra-pure biologics, industry is exploring a host of possibilities.

Key Takeaways
  • Biopharma is entering a transformative phase with space-based research.

Experts at a recent event highlighted the potential of the space environment in addressing some of key challenges in the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Focus On Asia

More from R&D